Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors

Código QR

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors

Guardado en:

Detalles Bibliográficos
Autores principales:	Vijeta Bajpai, Ekta Gupta, Aashish Chaudhary, Meenu Bajpai
Formato:	article
Lenguaje:	EN
Publicado:	Wolters Kluwer Medknow Publications 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/f0a3d8a47f2a403a8a1d7c666f4cc823
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Frequency of hepatitis B virus-DNA among hepatitis B surface-Ag negative, anti-hepatitis B core antibody-positive blood donors in Yazd, Iran
por: Mahtab Vaziri, et al.
Publicado: (2021)

MicroRNAs as B-cell lymphoma biomarkers
por: Manterola L, et al.
Publicado: (2015)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
por: Lim EL, et al.
Publicado: (2013)

Immune targeted therapy for diffuse large B cell lymphoma
por: Yaxin Zheng, et al.
Publicado: (2021)

TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
por: Ebru Pekgüç, et al.
Publicado: (2021)

INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT
por: Merih Reis Aras, et al.
Publicado: (2021)

Unexpected debris after post thawing donor stem cells in autologous transplantation
por: Basak Adaklı Aksoy, et al.
Publicado: (2021)

THE FREQUENCY OF HLA-A, B AND DRB1 ALLELES IN PATIENTS WITH BETA THALASSEMIA
por: Zeynep Karakas, et al.
Publicado: (2021)

Primary dural high grade B cell lymphoma mimicking subdural hematoma
por: Aya Nakaya, et al.
Publicado: (2021)

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future
por: Flowers CR, et al.
Publicado: (2012)

AN UNUSUAL SURVIVING HISTORY: MULTISYSTEM INVOLVEMENT UNTIL ADULT LIFE WITH NIEMANN PICK TYPE B
por: Özden ÖZLÜK, et al.
Publicado: (2021)

B-cell malignancies: capture-sequencing strategies for identification of gene rearrangements and translocations into immunoglobulin gene loci
por: Boyle EM, et al.
Publicado: (2014)

A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT
por: Mesut Tığlıoğlu, et al.
Publicado: (2021)

B1-CELLS OF INNATE IMMUNITY IN THE BONE MARROW IN BREAST CANCER PATIENTS: IDENTIFICATION AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL PARAMETERS
por: Svetlana Chulkova, et al.
Publicado: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Julio Delgado, et al.
Publicado: (2021)

A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
por: David MARKS, et al.
Publicado: (2021)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
por: Gupta VA, et al.
Publicado: (2013)

Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System
por: Yuu Oda, et al.
Publicado: (2021)

A Rare Cause of Acquired Factor X Deficiency in an 87-Year-Old Female
por: Ayrton Bangolo, et al.
Publicado: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Raffaella Pasquale, et al.
Publicado: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
por: Monarch Shah, et al.
Publicado: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
por: Jennifer Gill, et al.
Publicado: (2020)

All bleeding matters … but the details may not
por: Sarah H. O’Brien
Publicado: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
por: Eko A. Pangarsa, et al.
Publicado: (2021)

PP Transcon 2020 Abstracts Compilation
Publicado: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
por: Rasika D Setia, et al.
Publicado: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
por: Anand Deshpande, et al.
Publicado: (2021)

Oration - Dr Sanmukh Joshi
Publicado: (2021)

OP Transcon 2020 Abstracts Compilation
Publicado: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publicado: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
por: Shoumariyeh K, et al.
Publicado: (2014)

MYC as therapeutic target in leukemia and lymphoma
por: Cortiguera MG, et al.
Publicado: (2015)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
por: Moormann AM, et al.
Publicado: (2014)

Peripheral T cell lymphoma: clinical utility of romidepsin
por: Sawey K, et al.
Publicado: (2012)

The evaluation and optimal use of rituximab in lymphoid malignancies
por: Smolewski P, et al.
Publicado: (2012)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
por: Samuel sarmiento Doncel, et al.
Publicado: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
por: Brian Eyden, et al.
Publicado: (2021)